David please forward to the list. Thanks.Back to the Top
Dear Colleagues,
I would like to know what is considered as adequate
justification for NOT doing tissue distribution and
excretion studies in both male and female animals for
NDA submission? Say plasma PK is different between
males and females but toxicity profile is similar, is
this adequate for conducting tissue distribution and
excretion studies in males only?
Rostam
PharmPK Discussion List Archive Index page
Copyright 1995-2010 David W. A. Bourne (david@boomer.org)